Liminatus Pharma, Inc. financial statements
Liminatus Pharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 10.21M | 10-K |
| Cash and equivalents | USD 337.65K | 10-Q |
| Total debt | USD 1.44M | EODHD |
Liminatus Pharma, Inc. financials on 6ix · Liminatus Pharma, Inc. on 6ix